Antimicrobial peptides (AMPs) represent a promising therapeutic alternative for the
treatment of antibiotic-resistant bacterial infections. The present study investigates the …

In the search for new antimicrobial molecules, antimicrobial peptides (AMPs) offer a viable
alternative to conventional antibiotics, as they physically disrupt the bacterial membranes …

Antimicrobial peptides (AMPs) are being developed as potent alternative treatments to
conventional antibiotics which are unlikely to induce bacterial resistance. They can be …

Antimicrobial peptides (AMPs) represent a promising class of novel antimicrobial agents
owing to their potent antimicrobial activity. In this study, two lead peptides from unrelated …

Antimicrobial peptides (AMPs) are a class of broad-spectrum antibiotics known by their
ability to disrupt bacterial membranes and their low tendency to induce bacterial resistance …

Pseudomonas aeruginosa infection is a predominant cause of morbidity and mortality in
patients with cystic fibrosis infection and with a compromised immune system. Emergence of …

Multidrug resistant (MDR) pathogen infections are serious threats to hospitalized patients
because of the limited therapeutic options. A novel group of antibiotic candidates …

With the aim of tackling the increasingly serious antimicrobial resistance and improving the
clinical potential of AMPs, a facile de novo strategy was adopted in this study, and a series of …

The emergence and prevalence of multidrug-resistant (MDR) bacteria have posed a serious
threat to public health. Of particular concern are methicillin-resistant Staphylococcus aureus …

A new class of antimicrobial agents with lower rates of resistance and different targets is
urgently needed because of the rapidly increasing resistance to classical antibiotics …